Denali Therapeutics Inc. (DNLI) vs Neogen Corporation (NEOG)

A side-by-side comparison of Denali Therapeutics Inc. and Neogen Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — DNLI vs NEOG

growth of $100 · dividends reinvested · last 9y
DNLI -7.2% (-0.8%/yr)NEOG -57.8% (-9.1%/yr)DNLI compounded faster over this window
0100200300400Start $1002019202120232025$93$42
DNLI NEOG

DNLI vs NEOG: by the numbers

  • •DNLI is the larger company ($3.09B vs $2.62B market cap).
  • •Both run net losses; NEOG's is the smaller (-0.91% vs -14191.20% net margin).
  • •DNLI grew revenue faster over the past five years (20.68% vs 13.19% CAGR).

Metrics side by side

Valuation

MetricDNLINEOG
Forward P/EN/A38.81
P/S ratio858.063.01
P/B ratio3.701.25
EV / EBITDAN/A32.24

Profitability

MetricDNLINEOG
Gross margin0.00%46.93%
Operating margin0.00%-2.49%
Net margin-14191.20%-0.91%
ROE-61.24%-0.38%
ROIC-50.82%-0.68%

Growth (annualized)

MetricDNLINEOG
Revenue CAGR (5Y)20.68%13.19%
Total return CAGR (5Y)-16.91%-21.13%

Frequently asked

Which has grown faster, DNLI or NEOG?
Over the past five years, DNLI grew revenue faster — DNLI at a 20.68% CAGR versus NEOG at 13.19%.
How have DNLI and NEOG total returns compared?
Over the past 5 years, DNLI delivered -16.91% and NEOG delivered -21.13% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.